News|Articles|August 5, 2026

Eyes on July 2026: Approvals, pipeline momentum, and AI take center stage

Wet AMD gains a new FDA-approved therapy as retina, glaucoma, and dry eye pipelines surge—plus AI, devices, and workforce trends reshaping care.

July was a busy month for ophthalmology, with a major wet AMD approval, a wave of pipeline updates in retina and glaucoma, fresh thinking on dry eye disease, and continued debate over the specialty's workforce pressures.